Henrik Junger is currently the Integrated Product Medical Lead at Bayer, focusing on ECD Oncology since 2024. Previously, Junger served as a Postdoctoral Research Scholar in the Transplantation and Digital Pathology Laboratory at the University of California, San Francisco, from 2016 to 2018. They have also held the position of Group Leader and Guest Lecture at the Universitätsklinikum Regensburg in 2024. With past experience as a Research Scholar at the National Institute of Allergy and Infectious Diseases, Junger's career combines significant clinical and research expertise in the medical field. Junger is presently pursuing further education at Universität Regensburg.
Location
Regensburg, Germany
This person is not in the org chart
This person is not in any teams
This person is not in any offices